ImmunityBio Ownership | Who Owns ImmunityBio?


OverviewForecastRevenueFinancialsChart

ImmunityBio Ownership Summary


ImmunityBio is owned by 10.68% institutional investors, 66.41% insiders, and 22.91% retail investors. Vanguard group is the largest institutional shareholder, holding 3.11% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.77% of its assets in ImmunityBio shares.

IBRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunityBio10.68%66.41%22.91%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group27.66M3.11%$68.03M
Blackrock funding, inc. /de19.81M2.23%$48.73M
Blackrock11.42M1.70%$72.19M
Jane street group12.84M1.45%$31.58B
State street11.32M1.27%$27.84M
Geode capital management6.89M0.78%$16.95M
Heights capital management6.57M0.74%$16.15M
Woodline partners lp5.30M0.60%$13.03M
Morgan stanley3.37M0.38%$8.30M
Alphacore capital2.99M0.34%$7.35M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Heights capital management6.57M4.43%$16.15M
Kercheville advisors519.10K0.39%$1.28M
Alphacore capital2.99M0.25%$7.35M
Tang capital management2.33M0.22%$5.74M
Accurate wealth management560.00K0.19%$1.41M
Clearwater capital advisors846.42K0.18%$2.08M
Sheets smith wealth management633.08K0.18%$1.56M
Allen inc /ny687.57K0.16%$1.69M
Virtus investment advisers139.31K0.10%$342.70K
Collective family office161.28K0.10%$396.75K

Top Buyers

HolderShares% AssetsChange
Heights capital management6.57M4.43%6.57M
Vanguard group27.66M0.00%5.84M
Jane street group12.84M0.00%5.12M
State street11.32M0.00%3.70M
Blackrock funding, inc. /de19.81M0.00%2.04M

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.76M
Cormorant asset management, lp---3.00M
Octagon capital advisors lp---1.72M
Perceptive advisors---1.22M
Altium capital management lp---1.06M

New Positions

HolderShares% AssetsChangeValue
Heights capital management6.57M4.43%6.57M$16.15M
Renaissance1.02M0.00%1.02M$2.50M
Squarepoint ops1.01M0.00%1.01M$2.49M
Susquehanna portfolio strategies393.59K0.02%393.59K$968.22K
Quadrature capital262.39K0.01%262.39K$642.86K

Sold Out

HolderChange
Hfm investment advisors-4.00
Sjs investment consulting-9.00
Jfs wealth advisors-11.00
Investors research-15.00
Financial gravity asset management-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025181-26.42%94,869,384-19.91%106.01%85-45.51%4223.53%
Jun 30, 202525415.45%123,819,65152.36%1315.36%15932.50%37-13.95%
Mar 31, 20252204.27%81,251,228-1.72%96.75%1196.25%44-
Dec 31, 2024120-36.84%47,071,266-31.49%66.94%60-27.71%25-40.48%
Sep 30, 2024189-8.25%68,622,14511.64%912.32%85-23.42%41-12.77%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv7.29M0.77%-161.55K
Vanguard US Total Market Shares ETF5.72M0.67%1.43M
iShares Russell 2000 ETF5.48M0.58%-
Vanguard Small Cap Index5.36M0.57%-35.92K
SPDR® S&P Biotech ETF3.08M0.33%6.87K
Vanguard Small Cap Growth Index Inv3.00M0.32%-5.35K
Fidelity Small Cap Index2.31M0.24%757.22K
Vanguard Institutional Extnd Mkt Idx Tr2.19M0.23%-994.29K
iShares Russell 2000 Growth ETF1.65M0.17%-
JPM Thematics Genetic Thrps C2 Acc USD878.86K0.13%-30.90K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023SOON-SHIONG PATRICK See remarksBuy-
Jun 05, 2023BLASZYK MICHAEL D-Buy$132.96K
Jun 05, 2023BLASZYK MICHAEL D-Buy$1.33K
Jun 05, 2023BLASZYK MICHAEL D-Buy$63.73K
Jun 02, 2023Brennan John Owen-Buy$29.00K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

IBRX Ownership FAQ


Who Owns ImmunityBio?

ImmunityBio shareholders are primarily institutional investors at 10.68%, followed by 66.41% insiders and 22.91% retail investors. The average institutional ownership in ImmunityBio's industry, Biotech Stocks , is 45.22%, which ImmunityBio falls below.

Who owns the most shares of ImmunityBio?

ImmunityBio’s largest shareholders are Vanguard group (27.66M shares, 3.11%), Blackrock funding, inc. /de (19.81M shares, 2.23%), and Blackrock (11.42M shares, 1.70%). Together, they hold 7.04% of ImmunityBio’s total shares outstanding.

Does Blackrock own ImmunityBio?

Yes, BlackRock owns 1.70% of ImmunityBio, totaling 11.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 72.19M$. In the last quarter, BlackRock increased its holdings by 1.05M shares, a 10.10% change.

Who is ImmunityBio’s biggest shareholder by percentage of total assets invested?

Heights capital management is ImmunityBio’s biggest shareholder by percentage of total assets invested, with 4.43% of its assets in 6.57M ImmunityBio shares, valued at 16.15M$.

Who is the top mutual fund holder of ImmunityBio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ImmunityBio shares, with 0.77% of its total shares outstanding invested in 7.29M ImmunityBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools